Estados Unidos

Mercado internacional de ações

Cadastro completo das bolsas americanas, histórico de preços, demonstrações financeiras, indicadores, rentabilidade, crescimento, endividamento, qualidade, mercado e dividendos.

Ações ordinárias, common stocks e ADRs/ADSs ativos; ETFs, units, warrants, direitos e preferenciais ficam fora desta aba.

Explorar REITs americanos

5.660

ações no escopo

5.646

ligadas à SEC

5.651

com preços

5.119

com fundamentos

18/09/2026

última cotação

SEC como fonte principal

Identidade regulatória, demonstrações anuais e trimestrais e dividendos declarados vêm do EDGAR/XBRL.

Cadastro oficial

Nasdaq Trader cobre Nasdaq, NYSE, NYSE American, NYSE Arca, Cboe e IEX.

Proveniência explícita

A janela pública da Nasdaq tem prioridade; Yahoo Finance completa o período anterior sem ser rotulado como oficial.

Destaques do mercado

Ranking de Stocks

Listas objetivas calculadas sobre todo o universo de ações dos EUA, com preços de mercado e fundamentos SEC.

Top 5

Todas as ações

159 resultados

Ação	Bolsa	Preço	Valor de mercado	P/L

AMGNAmgen Inc. - Common Stock	NASDAQ	US$ 385,65	US$ 209,02 bi	27,10x	24,14x	89,06%	2,50%	Preço 18/09/2026 SEC 31/12/2025
GILDGilead Sciences, Inc. - Common Stock	NASDAQ	US$ 143,72	US$ 180,37 bi	21,20x	7,97x	37,62%	2,20%	Preço 11/09/2026 SEC 31/12/2025
ARGXargenx SE - American Depositary Shares	NASDAQ	US$ 990,32	US$ 61,28 bi	50,60x	8,37x	17,64%	—	Preço 18/09/2026 SEC 31/12/2025
MRNAModerna, Inc. - Common Stock	NASDAQ	US$ 143,97	US$ 56,00 bi	—	6,47x	-32,62%	—	Preço 11/09/2026 SEC 31/12/2025
RVMDRevolution Medicines, Inc. - Common Stock	NASDAQ	US$ 203,77	US$ 38,74 bi	—	23,75x	-69,35%	—	Preço 11/09/2026 SEC 31/12/2025
BIIBBiogen Inc. - Common Stock	NASDAQ	US$ 216,17	US$ 31,80 bi	24,59x	1,74x	7,08%	—	Preço 15/09/2026 SEC 31/12/2025
SCNIScinai Immunotherapeutics Ltd. - American Depositary Shares	NASDAQ	US$ 1,66	US$ 23,03 bi	—	2.842,04x	-102,52%	—	Preço 11/09/2026 SEC 31/12/2025
MESOMesoblast Limited - American Depositary Shares	NASDAQ	US$ 15,48	US$ 19,81 bi	—	33,16x	-17,10%	—	Preço 11/09/2026 SEC 30/06/2025
NBIXNeurocrine Biosciences, Inc. - Common Stock	NASDAQ	US$ 156,22	US$ 16,01 bi	33,45x	4,92x	14,71%	—	Preço 11/09/2026 SEC 31/12/2025
EXELExelixis, Inc. - Common Stock	NASDAQ	US$ 56,12	US$ 15,82 bi	20,19x	7,32x	36,21%	—	Preço 11/09/2026 SEC 02/01/2026
HALOHalozyme Therapeutics, Inc. - Common Stock	NASDAQ	US$ 107,20	US$ 13,28 bi	41,87x	272,10x	649,18%	—	Preço 11/09/2026 SEC 31/12/2025
TECHBio-Techne Corp - Common Stock	NASDAQ	US$ 72,27	US$ 11,35 bi	62,30x	5,38x	—	0,44%	Preço 14/09/2026 SEC 30/06/2026
KRYSKrystal Biotech, Inc. - Common Stock	NASDAQ	US$ 347,00	US$ 10,39 bi	50,73x	8,52x	16,80%	—	Preço 11/09/2026 SEC 31/12/2025
KYMRKymera Therapeutics, Inc. - Common Stock	NASDAQ	US$ 116,85	US$ 9,87 bi	—	6,25x	-19,71%	—	Preço 14/09/2026 SEC 31/12/2025
QGENQiagen N.V. Common Shares	NYSE	US$ 42,07	US$ 9,13 bi	21,69x	2,42x	11,25%	0,59%	Preço 14/09/2026 SEC 31/12/2025
PCVXVaxcyte, Inc. - Common Stock	NASDAQ	US$ 59,47	US$ 8,09 bi	—	3,01x	-28,55%	0,00%	Preço 11/09/2026 SEC 31/12/2025
TWSTTwist Bioscience Corporation - Common Stock	NASDAQ	US$ 127,22	US$ 7,61 bi	—	16,09x	-16,42%	—	Preço 11/09/2026 SEC 30/09/2025
IBRXImmunityBio, Inc. - Common Stock	NASDAQ	US$ 7,91	US$ 7,28 bi	—	-14,56x	70,34%	—	Preço 11/09/2026 SEC 31/12/2025
IMVTImmunovant, Inc. - Common Stock	NASDAQ	US$ 37,36	US$ 6,82 bi	—	7,99x	-59,30%	—	Preço 11/09/2026 SEC 31/03/2026
SRRKScholar Rock Holding Corporation - Common Stock	NASDAQ	US$ 55,41	US$ 6,36 bi	—	25,89x	-153,95%	—	Preço 11/09/2026 SEC 31/12/2025
CGONCG Oncology, Inc. - Common stock	NASDAQ	US$ 72,55	US$ 5,61 bi	—	7,45x	-21,39%	—	Preço 15/09/2026 SEC 31/12/2025
CRSPCRISPR Therapeutics AG - Common Shares	NASDAQ	US$ 51,83	US$ 4,66 bi	—	2,43x	-30,26%	—	Preço 15/09/2026 SEC 31/12/2025
ADPTAdaptive Biotechnologies Corporation - Common Stock	NASDAQ	US$ 28,61	US$ 4,34 bi	—	19,29x	-26,44%	—	Preço 18/09/2026 SEC 31/12/2025
DNLIDenali Therapeutics Inc. - Common Stock	NASDAQ	US$ 20,38	US$ 3,52 bi	—	3,47x	-50,56%	—	Preço 15/09/2026 SEC 31/12/2025
TARSTarsus Pharmaceuticals, Inc. - Common Stock	NASDAQ	US$ 79,31	US$ 3,31 bi	—	9,65x	-19,34%	0,00%	Preço 11/09/2026 SEC 31/12/2025
BEAMBeam Therapeutics Inc. - Common Stock	NASDAQ	US$ 23,10	US$ 2,28 bi	—	1,84x	-6,46%	—	Preço 16/09/2026 SEC 31/12/2025
ADMAADMA Biologics Inc - Common Stock	NASDAQ	US$ 9,11	US$ 2,23 bi	15,18x	4,67x	30,78%	—	Preço 18/09/2026 SEC 31/12/2025
VCELVericel Corporation - Common Stock	NASDAQ	US$ 38,34	US$ 2,00 bi	119,81x	5,64x	4,66%	—	Preço 11/09/2026 SEC 31/12/2025
BCRXBioCryst Pharmaceuticals, Inc. - Common Stock	NASDAQ	US$ 8,41	US$ 1,84 bi	6,95x	-15,44x	-221,45%	—	Preço 16/09/2026 SEC 31/12/2025
ALVOAlvotech - Ordinary Shares	NASDAQ	US$ 5,87	US$ 1,83 bi	58,70x	-6,44x	-9,81%	—	Preço 18/09/2026 SEC 31/12/2025
KODKodiak Sciences Inc - Common Stock	NASDAQ	US$ 32,89	US$ 1,75 bi	—	11,12x	-146,12%	—	Preço 11/09/2026 SEC 31/12/2025
INBXInhibrx Biosciences, Inc. - Common Stock	NASDAQ	US$ 109,27	US$ 1,69 bi	—	211,72x	-1.752,22%	—	Preço 11/09/2026 SEC 31/12/2025
DBVTDBV Technologies S.A. - American Depositary Shares	NASDAQ	US$ 11,76	US$ 1,64 bi	—	9,73x	-87,07%	—	Preço 15/09/2026 SEC 31/12/2025
IMCRImmunocore Holdings plc - American Depositary Shares	NASDAQ	US$ 32,60	US$ 1,64 bi	—	4,31x	-9,32%	0,00%	Preço 11/09/2026 SEC 31/12/2025
NVAXNovavax, Inc. - Common Stock	NASDAQ	US$ 9,42	US$ 1,63 bi	3,65x	-12,76x	-344,65%	—	Preço 11/09/2026 SEC 31/12/2025
TSHATaysha Gene Therapies, Inc. - Common Stock	NASDAQ	US$ 5,02	US$ 1,60 bi	—	6,50x	-44,14%	—	Preço 11/09/2026 SEC 31/12/2025
VIRVir Biotechnology, Inc. - Common Stock	NASDAQ	US$ 10,62	US$ 1,47 bi	—	1,92x	-57,23%	—	Preço 11/09/2026 SEC 31/12/2025
RXRXRecursion Pharmaceuticals, Inc. - Class A Common Stock	NASDAQ	US$ 3,20	US$ 1,43 bi	—	1,27x	-57,01%	—	Preço 11/09/2026 SEC 31/12/2025
QNCXQuince Therapeutics, Inc. - Common Stock	NASDAQ	US$ 27,37	US$ 1,37 bi	—	-38,39x	235,14%	—	Preço 14/09/2026 SEC 31/12/2025
EVAXEvaxion A/S - American Depositary Share	NASDAQ	US$ 3,13	US$ 1,31 bi	—	76,60x	-45,23%	—	Preço 11/09/2026 SEC 31/12/2025
REPLReplimune Group, Inc. - Common Stock	NASDAQ	US$ 12,92	US$ 1,20 bi	—	7,22x	-188,94%	—	Preço 11/09/2026 SEC 31/03/2026
IMTXImmatics N.V. - Ordinary Shares	NASDAQ	US$ 8,79	US$ 1,18 bi	—	2,43x	-40,58%	—	Preço 11/09/2026 SEC 31/12/2025
GLUEMonte Rosa Therapeutics, Inc. - Common Stock	NASDAQ	US$ 14,07	US$ 1,17 bi	—	5,02x	-16,57%	—	Preço 11/09/2026 SEC 31/12/2025
VALNValneva SE - American Depositary Shares	NASDAQ	US$ 6,66	US$ 1,16 bi	—	10,89x	-108,50%	—	Preço 11/09/2026 SEC 31/12/2025
MAZEMaze Therapeutics, Inc. - Common Stock	NASDAQ	US$ 24,60	US$ 1,06 bi	—	2,98x	-36,94%	—	Preço 11/09/2026 SEC 31/12/2025
MGTXMeiraGTx Holdings plc - Ordinary Shares	NASDAQ	US$ 12,79	US$ 1,03 bi	—	-177,58x	1.971,36%	—	Preço 11/09/2026 SEC 31/12/2025
SANASana Biotechnology, Inc. - Common Stock	NASDAQ	US$ 3,13	US$ 792,62 mi	—	4,93x	-151,77%	—	Preço 11/09/2026 SEC 31/12/2025
FDMT4D Molecular Therapeutics, Inc. - Common Stock	NASDAQ	US$ 13,17	US$ 762,94 mi	—	1,51x	-27,71%	—	Preço 11/09/2026 SEC 31/12/2025
SLDBSolid Biosciences Inc. - Common Stock	NASDAQ	US$ 8,70	US$ 761,29 mi	—	4,23x	—	—	Preço 11/09/2026 SEC 31/12/2025
CADLCandel Therapeutics, Inc. - Common Stock	NASDAQ	US$ 11,12	US$ 588,90 mi	—	11,34x	-73,54%	—	Preço 15/09/2026 SEC 31/12/2025
TECXTectonic Therapeutic, Inc. - Common Stock	NASDAQ	US$ 29,71	US$ 544,36 mi	—	2,17x	-29,50%	0,00%	Preço 14/09/2026 SEC 31/12/2025
AUTLAutolus Therapeutics plc - American Depositary Shares	NASDAQ	US$ 1,94	US$ 516,31 mi	—	2,90x	-161,42%	—	Preço 18/09/2026 SEC 31/12/2025
ZURAZura Bio Limited - Class A Ordinary shares	NASDAQ	US$ 5,21	US$ 490,57 mi	—	4,83x	-67,61%	—	Preço 11/09/2026 SEC 31/12/2025
PRMEPrime Medicine, Inc. - Common Stock	NASDAQ	US$ 3,13	US$ 465,61 mi	—	3,85x	-166,41%	—	Preço 11/09/2026 SEC 31/12/2025
RGNXREGENXBIO Inc. - Common Stock	NASDAQ	US$ 8,61	US$ 444,04 mi	—	4,32x	-188,72%	—	Preço 14/09/2026 SEC 31/12/2025
AURAAura Biosciences, Inc. - Common Stock	NASDAQ	US$ 6,44	US$ 388,57 mi	—	2,84x	-77,56%	—	Preço 18/09/2026 SEC 31/12/2025
DNAGinkgo Bioworks Holdings, Inc. Class A Common Stock	NYSE	US$ 6,99	US$ 387,65 mi	—	0,76x	-61,50%	—	Preço 15/09/2026 SEC 31/12/2025
ALLOAllogene Therapeutics, Inc. - Common Stock	NASDAQ	US$ 1,69	US$ 372,85 mi	—	1,27x	-65,25%	0,00%	Preço 18/09/2026 SEC 31/12/2025
KYTXKyverna Therapeutics, Inc. - Common Stock	NASDAQ	US$ 7,24	US$ 320,22 mi	—	1,38x	-69,45%	—	Preço 14/09/2026 SEC 31/12/2025
FENCFennec Pharmaceuticals Inc. - Common Stock	NASDAQ	US$ 10,96	US$ 313,20 mi	—	8,83x	-27,46%	—	Preço 11/09/2026 SEC 31/12/2025
CCCCC4 Therapeutics, Inc. - Common Stock	NASDAQ	US$ 3,43	US$ 284,33 mi	—	1,11x	-40,92%	—	Preço 15/09/2026 SEC 31/12/2025
FATEFate Therapeutics, Inc. - Common Stock	NASDAQ	US$ 2,31	US$ 274,40 mi	—	1,32x	-65,79%	—	Preço 11/09/2026 SEC 31/12/2025
EDITEditas Medicine, Inc. - Common Stock	NASDAQ	US$ 2,70	US$ 239,61 mi	—	8,78x	-586,56%	—	Preço 11/09/2026 SEC 31/12/2025
LCTXLineage Cell Therapeutics, Inc. Common Stock	NYSE American	US$ 1,04	US$ 239,32 mi	—	5,52x	-146,57%	—	Preço 14/09/2026 SEC 31/12/2025
AGENAgenus Inc. - Common Stock	NASDAQ	US$ 7,85	US$ 233,41 mi	—	-0,84x	—	—	Preço 18/09/2026 SEC 31/12/2025
IKTInhibikase Therapeutics, Inc. - Common Stock	NASDAQ	US$ 2,34	US$ 230,05 mi	—	1,33x	-27,91%	—	Preço 11/09/2026 SEC 31/12/2025
LXEOLexeo Therapeutics, Inc. - Common Stock	NASDAQ	US$ 4,26	US$ 228,80 mi	—	0,93x	-40,52%	—	Preço 14/09/2026 SEC 31/12/2025
CGENCompugen Ltd. - Ordinary Shares	NASDAQ	US$ 2,41	US$ 227,87 mi	6,34x	2,22x	34,40%	—	Preço 15/09/2026 SEC 31/12/2025
VORVor Biopharma Inc. - Common Stock	NASDAQ	US$ 22,30	US$ 220,14 mi	—	-1,34x	423,57%	—	Preço 11/09/2026 SEC 31/12/2025
ARTVArtiva Biotherapeutics, Inc. - Common Stock	NASDAQ	US$ 8,61	US$ 210,46 mi	—	1,91x	-76,26%	—	Preço 18/09/2026 SEC 31/12/2025
SABSSAB Biotherapeutics, Inc. - Common Stock	NASDAQ	US$ 3,41	US$ 209,17 mi	—	1,38x	8,76%	—	Preço 11/09/2026 SEC 31/12/2025
PLXProtalix BioTherapeutics, Inc. (DE) Common Stock	NYSE American	US$ 2,64	US$ 207,36 mi	—	4,30x	-13,69%	—	Preço 11/09/2026 SEC 31/12/2025
AVXLAnavex Life Sciences Corp. - Common Stock	NASDAQ	US$ 2,42	US$ 206,40 mi	—	2,18x	-48,89%	—	Preço 18/09/2026 SEC 30/09/2025
ALECAlector, Inc. - Common Stock	NASDAQ	US$ 1,91	US$ 196,73 mi	—	6,42x	-466,34%	—	Preço 18/09/2026 SEC 31/12/2025
ELOXEloxx Pharmaceuticals, Inc. - Common Stock	NASDAQ	US$ 15,75	US$ 194,47 mi	—	-16,33x	50,35%	—	Preço 11/09/2026 SEC 31/12/2025
CRDLCardiol Therapeutics Inc. - Class A Common Shares	NASDAQ	US$ 1,90	US$ 190,49 mi	—	10,66x	-189,17%	—	Preço 16/09/2026 SEC 31/12/2025
VYGRVoyager Therapeutics, Inc. - Common Stock	NASDAQ	US$ 3,19	US$ 187,22 mi	—	0,95x	-61,06%	—	Preço 11/09/2026 SEC 31/12/2025
IPHAInnate Pharma S.A. - American Depositary Shares	NASDAQ	US$ 1,87	US$ 175,26 mi	—	-8,07x	226,58%	—	Preço 11/09/2026 SEC 31/12/2025
MOLNMolecular Partners AG - American Depositary Shares	NASDAQ	US$ 4,18	US$ 168,77 mi	—	2,10x	-76,74%	—	Preço 11/09/2026 SEC 31/12/2025
NMRANeumora Therapeutics, Inc. - Common Stock	NASDAQ	US$ 1,03	US$ 168,28 mi	—	1,62x	-228,10%	—	Preço 14/09/2026 SEC 31/12/2025
IPSCCentury Therapeutics, Inc. - Common Stock	NASDAQ	US$ 1,94	US$ 167,92 mi	—	1,06x	-6,03%	—	Preço 11/09/2026 SEC 31/12/2025
TARAProtara Therapeutics, Inc. - Common Stock	NASDAQ	US$ 3,82	US$ 163,63 mi	—	0,83x	-29,24%	—	Preço 11/09/2026 SEC 31/12/2025
ABOSAcumen Pharmaceuticals, Inc. - Common Stock	NASDAQ	US$ 2,65	US$ 160,49 mi	—	2,28x	-172,28%	—	Preço 18/09/2026 SEC 31/12/2025
ACOGAlpha Cognition Inc. - Common Stock	NASDAQ	US$ 8,83	US$ 156,13 mi	—	2,50x	-33,06%	—	Preço 18/09/2026 SEC 31/12/2025
GRMLGreenland Mines Ltd - Common Stock	NASDAQ	US$ 3,15	US$ 152,74 mi	—	16,14x	-111,50%	—	Preço 11/09/2026 SEC 31/12/2025
ARMPArmata Pharmaceuticals, Inc. Common Stock	NYSE American	US$ 4,18	US$ 151,48 mi	—	-0,69x	79,51%	—	Preço 18/09/2026 SEC 31/12/2025
XFORX4 Pharmaceuticals, Inc. - Common Stock	NASDAQ	US$ 3,50	US$ 148,02 mi	—	0,79x	-42,51%	—	Preço 11/09/2026 SEC 31/12/2025
STROSutro Biopharma, Inc. - Common Stock	NASDAQ	US$ 16,91	US$ 143,70 mi	—	-1,08x	144,27%	—	Preço 14/09/2026 SEC 31/12/2025
CHRSCoherus Oncology, Inc. - Common Stock	NASDAQ	US$ 1,22	US$ 142,92 mi	0,85x	2,34x	275,39%	—	Preço 16/09/2026 SEC 31/12/2025
IVVDInvivyd, Inc. - Common Stock	NASDAQ	US$ 0,79	US$ 135,27 mi	—	0,56x	-21,73%	—	Preço 11/09/2026 SEC 31/12/2025
ENTXEntera Bio Ltd. - Ordinary Shares	NASDAQ	US$ 2,84	US$ 131,18 mi	11,36x	10,01x	-87,31%	—	Preço 11/09/2026 SEC 31/12/2025
LENZLENZ Therapeutics, Inc. - Common Stock	NASDAQ	US$ 4,46	US$ 128,51 mi	—	0,45x	-28,88%	—	Preço 14/09/2026 SEC 31/12/2025
ATRAAtara Biotherapeutics, Inc. - Common Stock	NASDAQ	US$ 9,69	US$ 123,24 mi	3,77x	-3,20x	-84,90%	—	Preço 18/09/2026 SEC 31/12/2025
CRBUCaribou Biosciences, Inc. - Common Stock	NASDAQ	US$ 1,25	US$ 116,74 mi	—	0,96x	-121,24%	—	Preço 16/09/2026 SEC 31/12/2025
PALIPalisade Bio, Inc. - Common Stock	NASDAQ	US$ 2,06	US$ 114,68 mi	—	0,89x	-12,97%	—	Preço 11/09/2026 SEC 31/12/2025
BDTXBlack Diamond Therapeutics, Inc. - Common Stock	NASDAQ	US$ 1,94	US$ 111,67 mi	4,97x	1,00x	19,93%	—	Preço 16/09/2026 SEC 31/12/2025
TNYATenaya Therapeutics, Inc. - Common Stock	NASDAQ	US$ 0,64	US$ 97,90 mi	—	0,79x	-73,50%	—	Preço 11/09/2026 SEC 31/12/2025
ENGNenGene Therapeutics Inc. - Common Stock	NASDAQ	US$ 1,80	US$ 92,02 mi	0,79x	0,55x	-69,94%	0,00%	Preço 11/09/2026 SEC 31/10/2025
CRDFCardiff Oncology, Inc. - Common Stock	NASDAQ	US$ 1,35	US$ 90,24 mi	—	1,99x	-101,02%	—	Preço 16/09/2026 SEC 31/12/2025
HUMAHumacyte, Inc. - Common Stock	NASDAQ	US$ 0,56	US$ 87,89 mi	—	28,27x	-1.313,38%	—	Preço 14/09/2026 SEC 31/12/2025

Mercado internacional de ações

Ranking de Stocks

Mais populares

Todas as ações

Maiores lucros

Maiores ROEs

Maiores altas